Sale!

SCN9A Gene Erythermalgia Primary Genetic Test

Original price was: $700.Current price is: $500.

-29%

The SCN9A Gene Erythermalgia Primary NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the SCN9A gene associated with primary erythermalgia, a rare neurological disorder characterized by intense burning pain, redness, and warmth in the extremities. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide precise genetic analysis for individuals experiencing unexplained burning sensations, skin redness, and temperature sensitivity. By detecting specific genetic variants, the test enables accurate diagnosis, facilitates personalized treatment approaches, and helps identify at-risk family members. The test is priced at $500 USD (discounted from $700) and provides results within 3-4 weeks, offering valuable insights for neurologists and genetic specialists in managing this complex condition.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

SCN9A Gene Erythermalgia Primary NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The SCN9A Gene Erythermalgia Primary NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise identification of mutations responsible for primary erythermalgia. This rare inherited condition affects the nervous system, causing debilitating symptoms that significantly impact quality of life. Our advanced testing methodology provides crucial insights for accurate diagnosis and targeted treatment strategies.

What Does This Test Measure?

This sophisticated genetic test specifically targets the SCN9A gene, which encodes the Nav1.7 sodium channel protein crucial for pain signal transmission in peripheral nerves. The test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the entire SCN9A gene, detecting:

  • Point mutations affecting sodium channel function
  • Missense mutations altering protein structure
  • Frameshift mutations disrupting normal gene expression
  • Deletion and insertion variants impacting channel properties
  • Specific genetic markers associated with inherited erythermalgia

Who Should Consider This Test?

This genetic test is particularly recommended for individuals experiencing:

  • Recurrent episodes of intense burning pain in hands and feet
  • Persistent skin redness and warmth in extremities
  • Temperature sensitivity triggering painful episodes
  • Family history of similar neurological symptoms
  • Unexplained chronic pain conditions unresponsive to conventional treatments
  • Early-onset neurological symptoms in childhood or adolescence

Clinical Benefits of Genetic Testing

Undergoing the SCN9A Gene Erythermalgia Primary NGS Genetic DNA Test provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out primary erythermalgia with high precision
  • Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
  • Family Planning: Provides crucial information for genetic counseling and family planning decisions
  • Early Intervention: Facilitates proactive management strategies before symptom progression
  • Differential Diagnosis: Helps distinguish between similar neurological conditions
  • Research Contribution: Contributes to ongoing scientific understanding of rare neurological disorders

Understanding Your Test Results

Our comprehensive genetic analysis provides detailed insights into your SCN9A gene status:

  • Positive Result: Indicates the presence of known pathogenic variants associated with primary erythermalgia, confirming diagnosis and guiding treatment
  • Negative Result: Suggests absence of common SCN9A mutations, though rare variants may require additional investigation
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications, requiring ongoing monitoring
  • Carrier Status: Determines inheritance patterns and risk assessment for family members

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3-4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Pre-Test Requirements

To ensure optimal testing accuracy, we require:

  • Complete clinical history documentation
  • Genetic counseling session with pedigree chart development
  • Detailed family medical history assessment
  • Informed consent for genetic testing

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and neurological specialists ensures comprehensive care coordination.

Take Control of Your Neurological Health

Don’t let unexplained neurological symptoms control your life. The SCN9A Gene Erythermalgia Primary NGS Genetic DNA Test provides the clarity needed for effective treatment planning and improved quality of life. Our team of genetic specialists and neurologists is ready to support you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Take the first step toward understanding your neurological health with confidence and precision.